Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Hangzhou AGS MedTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,442	1,177	1,032	1,955	213.38	204.53
Short-Term Investments	-	196.57	81.2	-	-	-
Trading Asset Securities	535.13	592.42	671.22	82.42	55.01	1.09
Cash & Short-Term Investments	1,977	1,966	1,784	2,037	268.4	205.62
Cash Growth	7.78%	10.20%	-12.42%	659.01%	30.53%	32.06%
Accounts Receivable	36.53	60.54	48.15	58.51	18.83	12.24
Other Receivables	1.78	-	-	1.18	2.11	2.04
Receivables	38.31	60.54	48.15	59.68	20.95	14.28
Inventory	58.17	59.65	56.38	46.8	38.57	39.89
Prepaid Expenses	-	-	-	0.05	0.1	-
Other Current Assets	310.65	7.85	5.76	2.45	3.88	2.78
Total Current Assets	2,384	2,094	1,894	2,146	331.89	262.56
Property, Plant & Equipment	227.37	201.27	200.09	159.7	117.67	54.89
Long-Term Investments	45.95	316.67	432.43	-	-	-
Other Intangible Assets	47.85	48.45	18.27	19	19.72	19.95
Long-Term Deferred Tax Assets	1.8	2.14	1.24	1.9	0.36	0.3
Long-Term Deferred Charges	3.5	3.9	2.77	2.35	3.3	3.18
Other Long-Term Assets	19.98	10.12	0.58	1.99	0.19	1.12
Total Assets	2,731	2,677	2,550	2,331	473.13	341.99

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	59.11	40.6	66.02	48.41	32.05	37.65
Accrued Expenses	20.07	32.9	40.84	34.79	24.29	9.13
Short-Term Debt	70.12	35	-	-	-	-
Current Portion of Leases	-	1.41	1.3	0.57	1.08	0.94
Current Income Taxes Payable	11.35	9.71	17.49	14.95	15.7	6.95
Current Unearned Revenue	10.61	12.66	8.28	5.14	7.15	8.77
Other Current Liabilities	1.88	19.61	8.05	16.88	10.76	5.56
Total Current Liabilities	174.46	151.9	141.99	120.73	91.03	69
Long-Term Leases	0.11	0.85	2.15	-	0.57	1.39
Long-Term Unearned Revenue	7.15	7.61	8.53	2.1	-	-
Long-Term Deferred Tax Liabilities	0.01	0.01	-	-	-	0.16
Total Liabilities	181.74	160.37	152.67	122.83	91.59	70.55

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	81.12	81.12	80.98	57.87	43.4	43.4
Additional Paid-In Capital	1,718	1,716	1,725	1,715	76.53	76.53
Retained Earnings	766.24	732.38	621.87	434.79	261.54	151.62
Treasury Stock	-13.65	-13.65	-30.97	-	-	-
Comprehensive Income & Other	-3.23	1.17	0.1	0.11	0.07	-0.1
Total Common Equity	2,548	2,517	2,397	2,208	381.54	271.45
Minority Interest	0.63	-0.47	-	-	-	-
Shareholders' Equity	2,549	2,516	2,397	2,208	381.54	271.45
Total Liabilities & Equity	2,731	2,677	2,550	2,331	473.13	341.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	71.55	37.26	3.45	0.57	1.64	2.32
Net Cash (Debt)	1,905	1,929	1,781	2,037	266.75	203.3
Net Cash Growth	4.05%	8.32%	-12.57%	663.48%	31.21%	30.57%
Net Cash Per Share	23.66	23.97	22.10	28.06	4.39	3.35
Filing Date Shares Outstanding	81.06	81.1	80.58	81.02	60.76	60.76
Total Common Shares Outstanding	81.06	81.1	80.58	81.02	60.76	60.76
Working Capital	2,210	1,942	1,752	2,025	240.86	193.57
Book Value Per Share	31.43	31.03	29.75	27.26	6.28	4.47
Tangible Book Value	2,500	2,468	2,379	2,189	361.82	251.5
Tangible Book Value Per Share	30.84	30.43	29.52	27.02	5.95	4.14
Buildings	-	166.44	164.61	71.12	26.84	26.84
Machinery	-	62.09	52.19	41.56	7.7	28.88
Construction In Progress	-	8.93	8.65	67.92	72.65	10.55

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error